Skip to main content

Day: July 30, 2020

Citizens Community Bancorp, Inc. Earns $3.1 Million, or $0.28 Per Share in 2Q20, SBA Paycheck Protection Program Loan Production of $137 Million, Record Mortgage Originations of $82 Million

EAU CLAIRE, Wis., July 30, 2020 (GLOBE NEWSWIRE) — Citizens Community Bancorp, Inc. (the “Company”) (Nasdaq: CZWI), the parent company of Citizens Community Federal N.A. (the “Bank” or “CCFBank”), today reported earnings of $3.1 million, or $0.28 per diluted share for the quarter ended June 30, 2020, compared to $2.6 million, or $0.23 per diluted share for the previous quarter ended March 31, 2020.  Tangible book value per share (non-GAAP)5 was $10.31 at June 30, 2020 compared to $9.80 at March 31, 2020.  This increase in tangible book value reflects the second quarter net income of $3.1 million, quarterly increase in accumulated other comprehensive income of $1.6 million and a reduction of intangibles of $0.9 million, including a reduction of $0.5 million from the sale of the Wells Insurance Agency.  For the six months ended June...

Continue reading

Corbus Pharmaceuticals to Report Second Quarter Results on August 6, 2020 

Management to host conference call and webcast on Thursday, August 6 at 8:30 a.m. ETNorwood, MA, July 30, 2020 (GLOBE NEWSWIRE) — Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) (“Corbus” or the “Company”), a clinical-stage drug development company pioneering transformative medicines that target the endocannabinoid system, today announced that it will report its second quarter financial results on Thursday, August 6. Corbus management will host a conference call and live audio webcast to discuss operational and financial results at 8:30 a.m. ET that same day.The call will be led by Yuval Cohen, Ph.D., Chief Executive Officer of Corbus. He will be joined by additional members of the Corbus management team. Interested participants and investors may access the conference call by dialing (877) 407-3978 (domestic) or (412) 902-0039...

Continue reading

Microchip Introduces First Time and Frequency Instrument with Embedded Global Positioning System (GPS) M-Code Receiver

CHANDLER, Ariz., July 30, 2020 (GLOBE NEWSWIRE) — Threats from intentional jamming and spoofing of U.S. Global Positioning System (GPS) signals, as well as cybersecurity risks to critical infrastructure, demonstrate the need for powerful and secure time and frequency systems that ensure continuing operability and performance. Microchip Technology Inc. (Nasdaq: MCHP) today announced that its SyncServer S650 M-Code time server has received approval from the U.S. Air Force GPS Directorate of the Los Angeles Air Force Base for use in support of military communication systems, radars and networks.M-Code, an encrypted military signal broadcasted in GPS frequency bands, is required by congressional mandate for mission critical Department of Defense (DoD) applications in hostile environments. Microchip’s SyncServer S650 M-Code equipped...

Continue reading

America First Multifamily Investors, L.P. Extends Maturity of $50 Million Unsecured Line of Credit Commitment

OMAHA, Neb., July 30, 2020 (GLOBE NEWSWIRE) — On July 28, 2020, America First Multifamily Investors, L.P. (NASDAQ: ATAX) (the “Partnership”) entered into a Seventh Amendment to Credit Agreement (the “Seventh Amendment”) with Bankers Trust Company (“Bankers Trust”) which modifies certain provisions of the Credit Agreement entered into between the Partnership and Bankers Trust on May 14, 2015, as amended.  The Seventh Amendment extends the maturity date of the Partnership’s $50 million unsecured, non-operating line of credit (“Non-operating LOC”) to June 30, 2022. The Partnership also entered into an updated Revolving Line of Credit Note which include new terms related to a LIBOR index rate floor of 10 basis points.  “The extension of the maturity date of the Partnership’s $50 million Non-operating LOC continues our strong relationship...

Continue reading

RECORDATI ANNOUNCES POSITIVE FIRST HALF 2020 RESULTS. REVENUES +2.3%, EBITDA +11.4%, ADJUSTED NET INCOME +16.8%

RECORDATI ANNOUNCES POSITIVE FIRST HALF 2020 RESULTS. REVENUES +2.3%, EBITDA +11.4%, ADJUSTED NET INCOME +16.8%Consolidated revenues € 760.2 million, +2.3%.EBITDA (1) € 311.1 million, +11.4%Operating income € 261.5 million, +7.8%Net income € € 196.9 million, + 13.0%Adjusted net income (2) € 225.6 million, +16.8%Net financial position (3):  net debt of € 922.4 million; € 902.7 million at 31 December 2019Shareholders’ equity € 1,242.0 millionIsturisa® (osilodrostat) Launched in the U.S.A., France and Germany. Filed for approval in Japan.Full year 2020 targets updated Milan, 30 July 2020 – The Board of Directors of Recordati S.p.A. approved the Group’s consolidated results for the first half 2020 prepared in accordance with the International Financial Reporting Standards (IAS/IFRS) and in particular as per IAS 34 requirements for interim...

Continue reading

RECORDATI: RISULTATI ECONOMICI POSITIVI NEL PRIMO SEMESTRE DEL 2020. RICAVI +2,3%, EBITDA +11,4%, UTILE NETTO RETTIFICATO +16,8%

RECORDATI: RISULTATI ECONOMICI POSITIVI NEL PRIMO SEMESTRE DEL 2020. RICAVI +2,3%, EBITDA +11,4%, UTILE NETTO RETTIFICATO +16,8%Ricavi netti consolidati € 760,2 milioni, +2,3%.EBITDA (1) € 311,1 milioni, +11,4%.Utile operativo € 261,5 milioni, +7,8%.Utile netto € 196,9 milioni, + 13,0%.Utile netto rettificato (2) € 225,6 milioni, +16,8%.Posizione finanziaria netta (3): debito netto di € 922,4 milioni; € 902,7 milioni al 31 dicembre 2019.Patrimonio netto € 1.242,0 milioni.Isturisa® (osilodrostat) Iniziata la commercializzazione negli Stati Uniti d’America, Francia e Germania. Richiesta autorizzazione presentata in Giappone.Aggiornate le previsioni per l’intero anno 2020.Milano, 30 luglio 2020 – Il Consiglio di Amministrazione della Recordati S.p.A. ha approvato la relazione finanziaria semestrale al 30 giugno 2020, ai sensi dell’art. 154-ter...

Continue reading

Aura Minerals Announces Second Quarter 2020 Earnings Call

ROAD TOWN, British Virgin Islands, July 30, 2020 (GLOBE NEWSWIRE) — Aura Minerals Inc. (TSX: ORA) (B3: AURA32) (“Aura” or the “Company”) today announced it will report its financial and operating results for the second quarter and first half of 2020 after the market closes on Wednesday, August 5, 2020. Aura will subsequently hold a conference call at 9:00 a.m. Eastern Time on Thursday, August 6, 2020 to discuss the results. Those wishing to join the call can do so using the information posted below.Conference Call DetailsDate: Thursday, August 6, 2020, 9:00 a.m. Eastern TimeToll Free Dial-In Number: +1 844 204-8942International Callers: +1 412 717-9627 or +55 11 4210-1803 (Brazil)Webcast: in English: https://webcastlite.mziq.com/cover.html?webcastId=19a76729-683f-4b50-83a2-3999954739b6 andin Portuguese: https://webcastlite.mziq.com/cover.html?webcastId=6b176f9e-756b-43cd-8ad9-6ac95c302b1bThe...

Continue reading

Cynata Completes Phase 1 GvHD Clinical Trial Follow-up with Positive Results

MELBOURNE, Australia, July 30, 2020 (GLOBE NEWSWIRE) — Cynata Therapeutics Limited (ASX: “CYP”, “Cynata”, or the “Company”), a clinical-stage biotechnology company specialising in cell therapeutics, has today announced positive results from the two-year follow-up of patients enrolled in the Phase 1 clinical trial of CYP-001, Cynata’s lead induced pluripotent stem cell (iPSC)-derived Cymerus™ mesenchymal stem cell (MSC) product. The Phase 1 trial, which was the world’s first clinical trial of an allogeneic iPSC-derived MSC product, evaluated the safety and efficacy of CYP-001 for the treatment of patients with steroid-resistant acute graft-versus-host disease (GvHD).Highlights:Overall survival after two years was 60% (9/15 patients), which compares favourably to previously published outcomes in this patient populationNo treatment-related...

Continue reading

ABM Industries Names Chief Information Officer

NEW YORK, July 30, 2020 (GLOBE NEWSWIRE) — ABM (NYSE: ABM), a leading provider of facility solutions, announced Melanie Kirkwood Ruiz as the Company’s Chief Information Officer, reporting directly to ABM’s Chief Strategy and Transformation Officer, Josh Feinberg.Melanie joined ABM from Cushman & Wakefield, where she was responsible for developing the technology strategy in the Americas, and oversaw the change agenda focused on innovation, integration and optimization. She is a progressive technology leader with 20 years of experience across diverse industries including technology, commercial real estate, manufacturing, healthcare and aviation. “We’re thrilled to have Melanie on the ABM team,” said Mr. Feinberg. “Her skill set and experience spans a range of industries, many of which align with ABM’s end-markets. Under her leadership,...

Continue reading

Misonix to Present at the 40th Annual Canaccord Genuity Growth Conference

FARMINGDALE, N.Y., July 30, 2020 (GLOBE NEWSWIRE) — Misonix, Inc. (Nasdaq: MSON), a provider of minimally invasive therapeutic ultrasonic medical devices and regenerative products that enhance clinical outcomes, today announced that it will be participating in the 40th Annual Canaccord Genuity Growth Conference. Misonix Chief Executive Officer, Stavros Vizirgianakis, along with Joe Dwyer, Misonix Chief Financial Officer, will be making a virtual company presentation on Wednesday, August 12th at 10:30 a.m. ET. Management will also be available to speak with institutional investors in one-on-one virtual meetings throughout the day on August 12th and 13th.If you have questions about Misonix or are interested in conducting a conference call or meeting with management, please contact the Company’s investor relations firm, JCIR, at (212)...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.